CLINICAL_TRIALS
research
· 2025-05-28
Clinical Trial Update: Colchicine After Electrocardioversion for Atrial Fibrillation [Phase 3]
Summary
A Phase 3 clinical trial evaluating the use of colchicine after electrical cardioversion for atrial fibrillation is currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University Hospital, Basel, Switzerland | Conditions: Atrial Fibrillation, Cardiac Arrhythmia | Phase 3 | Status: RECRUITING